Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Hematologic Neoplasms

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Hematologic Neoplasms:

Pubmed Logo
p38 Mitogen-activated protein kinase and hematologic malignancies.
CONTEXT: p38 mitogen-activated protein kinase (MAPK) signaling has been...
18th November, 2009
Department of Pathology, The Methodist Hospital and The Methodist Hospital Arch Pathol Lab Med. 2009 Nov;133(11):1850-6.
[Research progress of zebrafish as a model system for hematological neoplasms]
Zebrafish is becoming a powerful vertebrate model for studies of human...
13th November, 2009
Department of Hematology, RenJi Hospital and Laboratory of Leukemia, Yi Chuan. 2009 Sep;31(9):889-95.
Neonatal intravenous injection of a gammaretroviral vector has a low incidence of tumor induction in mice.
Neonatal intravenous injection of gammaretroviral vectors (gamma-RVs) with...
11th November, 2009
Department of Internal Medicine, Washington University School of Medicine, Hum Gene Ther. 2008 Nov;19(11):1317-23.
Present status and perspectives regarding the therapeutic strategy for acute myeloid leukemia, non-Hodgkin's lymphoma and multiple myeloma in the elderly.
The incidence of cancers increases with advancing age. To improve the...
11th November, 2009
Department of Hematology, Tokyo Metropolitan Geriatric Hospital, Geriatr Gerontol Int. 2009 Jun;9(2):115-23.
DOI Direct Link
TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
Inhibition of tumor growth factor (TGF)-beta-mediated cell cycle exit is...
7th November, 2009
Department of Plant Biology and Forest Genetics, Uppsala Genetic Center, Exp Cell Res. 2009 Nov 1;315(18):3099-111. Epub 2009 Sep 17.
DOI Direct Link

View more research publications.

Press Releases About Hematologic Neoplasms:

BioPortfolio Logo
The American Society of Hematology Elects New Leadership 3rd November, 2009 American Society of Hematology
WASHINGTON, Nov. 3 /PRNewswire-USNewswire/ -- The American Society of Hematology, the world's largest professional society of blood specialists, welcomes five new officers to its Executive
Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 30th October, 2009 Shire plc
HONOLULU, Oct. 30 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb
New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohn's Patients 26th October, 2009 UCB
-- Bacterial, viral and other infections due to opportunistic pathogens. The risks and benefits of treatment with CIMZIA should be carefully considered prior to initiating therapy in patients
New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure 26th October, 2009 UCB
-- Efficacy of certolizumab pegol is not affected by baseline anti-infliximab antibody status in patients with Crohn's disease with secondary infliximab failure (Abstract
UCB's Cimzia(R) (certolizumab pegol), Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid Arthritis 17th October, 2009 UCB
-- Bacterial, viral and other infections due to opportunistic pathogens. The risks and benefits of treatment with Cimzia® should be carefully considered prior to initiating therapy in

Hematologic Neoplasms Patents:

USPTO Logo
US Patent No.Title
7449303 Use of JAG2 expression in diagnosis of plasma cell disorders
5734039 Antisense oligonucleotides targeting cooperating oncogenes
5670477 Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents
5670317 Diagnostic test for the desmoplastic small round cell tumor
5663197 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4,9-dione and antitumor agents comprising this compound

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Hematologic Neoplasms scientists - we have details of around 453 individuals working on Hematologic Neoplasms .


This page has been viewed 375 times
Recent Search Terms used to find this page: US patent 5663197 | V617F mutation, wikipedia | what is hematological neoplasms | BMS-863233 | what is hematologic neoplasm | what is hematologic neoplasms | haploidentical transplantation wiki | leukemia hematological neoplasms | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hematologic Neoplasms across BioPortfolio, or for Hematologic Neoplasms Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.